Announcement under Regulation 30- expansion of manufacturing capacity at Ankleshwar Plant, Gujarat
ELANTAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.5 pts more than Nifty Microcap 250 and 3.0 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board of Elantas Beck India has approved an investment of approximately Rs. 56 crore to expand manufacturing capacity at its Ankleshwar plant in Gujarat. The plant currently operates at 35,000 MT per year with 90% utilization, and the company plans to add 11,000 MT per year (around 31% capacity increase) within 12 months. The expansion will be financed entirely through internal accruals, with no debt raised. The company stated the move is aimed at supporting future growth, easing operational bottlenecks, and improving supply reliability for key products. Board approval was granted at the meeting held on June 2, 2026.
The expansion signals strong demand outlook and proactive capacity building, funded internally without leverage, which is positive for shareholders. With current utilization already at 90%, the added capacity positions the company to capture future growth, though near-term margin pressure from the capex spend cannot be ruled out.